Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE: 2196.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yi Liu
- Employees
- 40,557
- Headquarters
- Shanghai, China
- IPO year
- 2012
- Market cap
- HK$71.4B
- Website
- https://www.fosunpharma.com
Loading 2196…
Loading profile data…Frequently asked questions about 2196
What does Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) do?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers...
Where does 2196.HK trade?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) trades on the Hong Kong Stock Exchange.
What sector is 2196.HK in?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.?
Yi Liu is the chief executive officer of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK).
Where is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. headquartered?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is headquartered in China.
Does 2196.HK pay a dividend?
Yes — Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) paid a trailing twelve-month dividend of HKD 0.35 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2196.HK go public?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) completed its initial public offering in 2012.